Potentials of long noncoding RNAs (LncRNAs) in sarcoma: From biomarkers to therapeutic targets

31Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Sarcoma includes some of the most heterogeneous tumors, which make the diagnosis, prognosis and treatment of these rare yet diverse neoplasms especially challenging. Long noncoding RNAs (lncRNAs) are important regulators of cancer initiation and progression, which implies their potential as neoteric prognostic and diagnostic markers in cancer, including sarcoma. A relationship between lncRNAs and sarcoma pathogenesis and progression is emerging. Recent studies demonstrate that lncRNAs influence sarcoma cell proliferation, metastasis, and drug resistance. Additionally, lncRNA expression profiles are predictive of sarcoma prognosis. In this review, we summarize contemporary advances in the research of lncRNA biogenesis and functions in sarcoma. We also highlight the potential for lncRNAs to become innovative diagnostic and prognostic biomarkers as well as therapeutic targets in sarcoma.

Cite

CITATION STYLE

APA

Min, L., Garbutt, C., Tu, C., Hornicek, F., & Duan, Z. (2017, April 1). Potentials of long noncoding RNAs (LncRNAs) in sarcoma: From biomarkers to therapeutic targets. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms18040731

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free